KK
BPMC

KLP Kapitalforvaltning’s Blueprint Medicines BPMC Stock Holding History

KLP Kapitalforvaltning’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,300
Closed -$1.09M – 2199
2025
Q1 		$1.09M Sell
12,300
-600
-5% -$58.5K 0.01% 891
2024
Q4 		$1.13M Buy
+12,900
New +$1.18M 0.01% 930

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KLP Kapitalforvaltning's BPMC Position: Q2 2025 in Review

KLP Kapitalforvaltning sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 12,300 shares — an estimated $1.09M sold.

KLP Kapitalforvaltning first reported a position in BPMC in Q4 2024 and held it in 2 quarters. The position peaked at $1.13M in Q4 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • KLP Kapitalforvaltning reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 12,300 Blueprint Medicines shares in Q2 2025, an estimated $1.09M.
  • KLP Kapitalforvaltning first reported a position in Blueprint Medicines in Q4 2024 and held it in 2 quarters.
  • KLP Kapitalforvaltning's Blueprint Medicines position peaked at $1.13M in Q4 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2025, filed 23 Jul 2025.